0001183740-19-000030.txt : 20190225 0001183740-19-000030.hdr.sgml : 20190225 20190225170451 ACCESSION NUMBER: 0001183740-19-000030 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20190225 DATE AS OF CHANGE: 20190225 EFFECTIVENESS DATE: 20190225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PharmaCielo Holdings Ltd. CENTRAL INDEX KEY: 0001641777 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-316289 FILM NUMBER: 19630353 BUSINESS ADDRESS: STREET 1: 82 RICHMOND STREET EAST, SUITE 200 CITY: TORONTO STATE: A6 ZIP: M5C 1P1 BUSINESS PHONE: 6475604640 MAIL ADDRESS: STREET 1: 82 RICHMOND STREET EAST, SUITE 200 CITY: TORONTO STATE: A6 ZIP: M5C 1P1 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCielo Ltd. DATE OF NAME CHANGE: 20150507 D/A 1 primary_doc.xml X0708 D/A LIVE 0001641777 PharmaCielo Holdings Ltd. 82 RICHMOND STREET EAST, SUITE 200 TORONTO A6 ONTARIO, CANADA M5C 1P1 6475604640 CANADA (FEDERAL LEVEL) PharmaCielo Ltd. Corporation true 2014 Scott Laitinen 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Executive Officer Henning von Koss 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Director Carlos Uribe 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Director Delon Human 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Director David Attard 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Executive Officer Director Federico Cock-Correa 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Director David Gordon 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Executive Officer Matteo Pellegrini 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Director Simon Langelier 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Director Douglas Bache 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Director Pharmaceuticals Decline to Disclose 06c true 0001183740-18-000126 2018-06-25 false true true true true 2,504,746 Subscription Receipts at C$3.35 per Subscription Receipt, convertible into shares upon satisfaction of escrow release conditions at or before September 30, 2018. true In connection with the acquisition of all the issued and outstanding shares of the Issuer by AAJ Capital 1 Corp. ("AAJ") by way of a three-cornered merger pursuant to a merger agreement between the Issuer, AAJ and a wholly-owned subsidiary of AAJ. 17627 6315156 6315156 0 2,504,746 Subscription Receipts were sold at C$3.35 per Subscription Receipt (US$2.52 per Subscription Receipt, based on exchange rate of US$1:C$1.3303 on 6/25/2018; US$2.56 per Subscription Receipt, based on exchange rate of US$1:C$1.3088 on 7/25/2018). false 107 0 0 0 false PharmaCielo Holdings Ltd. /s/ Scott Laitinen Scott Laitinen Chief Financial Officer 2019-02-11